RU93053630A - Новые стероиды, способ их получения, фармацевтический препарат, способ лечения - Google Patents

Новые стероиды, способ их получения, фармацевтический препарат, способ лечения

Info

Publication number
RU93053630A
RU93053630A RU93053630/04A RU93053630A RU93053630A RU 93053630 A RU93053630 A RU 93053630A RU 93053630/04 A RU93053630/04 A RU 93053630/04A RU 93053630 A RU93053630 A RU 93053630A RU 93053630 A RU93053630 A RU 93053630A
Authority
RU
Russia
Prior art keywords
treatment
producing
pharmaceutical drug
new steroids
steroids
Prior art date
Application number
RU93053630/04A
Other languages
English (en)
Other versions
RU2111212C1 (ru
Inventor
Андерссон Пауль
Аксельссон Бенгт
Браттсанд Ральф
Гален Арне
Original Assignee
Актиеболагет Астра
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9100341A external-priority patent/SE9100341D0/xx
Application filed by Актиеболагет Астра filed Critical Актиеболагет Астра
Publication of RU93053630A publication Critical patent/RU93053630A/ru
Application granted granted Critical
Publication of RU2111212C1 publication Critical patent/RU2111212C1/ru

Links

Claims (1)

  1. Предложены 22R или 22S-эпимер соединения общей формулы I
    Figure 00000001

    где X1 - атом фтора; X2 - атом водорода или атом фтора, способы их приготовления, фармацевтические препараты, содержащие их, и использование этих соединений в лечении воспалительных и аллергических заболеваний.
RU93053630A 1991-02-04 1992-01-29 22r- или 22s-эпимеры соединения, способ их получения, фармацевтическая композиция и способ лечения аллергических и воспалительных заболеваний RU2111212C1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9100341-8 1991-02-04
SE9100341A SE9100341D0 (sv) 1991-02-04 1991-02-04 Novel steroids
SE9100341.3 1991-02-04
PCT/SE1992/000055 WO1992013872A1 (en) 1991-02-04 1992-01-29 Novel steroids

Publications (2)

Publication Number Publication Date
RU93053630A true RU93053630A (ru) 1997-04-20
RU2111212C1 RU2111212C1 (ru) 1998-05-20

Family

ID=20381806

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93053630A RU2111212C1 (ru) 1991-02-04 1992-01-29 22r- или 22s-эпимеры соединения, способ их получения, фармацевтическая композиция и способ лечения аллергических и воспалительных заболеваний

Country Status (40)

Country Link
US (2) US5674861A (ru)
EP (1) EP0570454B1 (ru)
JP (1) JPH06505232A (ru)
KR (1) KR100216720B1 (ru)
CN (3) CN1034868C (ru)
AP (1) AP366A (ru)
AT (1) ATE178611T1 (ru)
BG (1) BG62211B1 (ru)
CA (1) CA2103924A1 (ru)
CZ (1) CZ281685B6 (ru)
DE (1) DE69228870T2 (ru)
DK (1) DK0570454T3 (ru)
DZ (1) DZ1553A1 (ru)
EE (1) EE03111B1 (ru)
ES (1) ES2133315T3 (ru)
FI (1) FI933450A (ru)
GR (1) GR3030657T3 (ru)
HK (1) HK1010733A1 (ru)
HU (1) HU218275B (ru)
IE (1) IE920166A1 (ru)
IL (1) IL100532A (ru)
IS (1) IS1601B (ru)
MA (1) MA22406A1 (ru)
MX (1) MX9200324A (ru)
NO (1) NO304073B1 (ru)
NZ (1) NZ241210A (ru)
PH (1) PH31284A (ru)
PL (1) PL170000B1 (ru)
PT (1) PT100086B (ru)
RO (1) RO111195B1 (ru)
RU (1) RU2111212C1 (ru)
SE (1) SE9100341D0 (ru)
SG (1) SG52557A1 (ru)
SI (1) SI9210065B (ru)
SK (1) SK281801B6 (ru)
TN (1) TNSN92007A1 (ru)
UA (1) UA41267C2 (ru)
WO (1) WO1992013872A1 (ru)
YU (1) YU48892B (ru)
ZA (1) ZA92233B (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
KR960700266A (ko) * 1993-01-08 1996-01-19 클래스 빌헬름슨 신규 결장- 또는 회장-특이성 스테로이드 유도체(Novel Colon-or lleum-Specific Steroid Derivatives)
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
GB9423919D0 (en) * 1994-11-26 1995-01-11 Rhone Poulenc Rorer Ltd Chemical process
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
IT1291288B1 (it) * 1997-04-30 1999-01-07 Farmabios Srl Processo per la preparazione di 16,17 acetali di derivati pregnanici con controllo della distribuzione epimerica al c-22.
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
GB0009607D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
HRP20010018A2 (en) 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
GB0110411D0 (en) * 2001-04-27 2001-06-20 Astrazeneca Ab Chemical process
EP1465915A1 (en) * 2001-09-25 2004-10-13 PHARMACIA & UPJOHN COMPANY Stereoselective transacetalization of steroidal c-22 acetonide
NZ537717A (en) 2002-07-08 2006-04-28 Pliva Istrazivacki Inst D New compounds, compositions and methods for treatment of inflammatory diseases and conditions
AU2003264917A1 (en) 2002-07-08 2004-01-23 Pliva - Istrazivacki Institut D.O.O. Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
WO2004017904A2 (en) * 2002-08-23 2004-03-04 The Mclean Hospital Corporation Corticosteroid conjugates and uses thereof
TW200417371A (en) * 2003-02-21 2004-09-16 Upjohn Co A continuous process for the production of R-rofleponide
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
HRP20030604A2 (en) 2003-07-25 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromenes, preparation thereof andtheir antiinflammatory action
HRP20030603A2 (en) 2003-07-25 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromene compounds of antiinflammatory action
ATE453658T1 (de) 2004-10-27 2010-01-15 Glaxosmithkline Zagreb Konjugate mit entzündungshemmender aktivität
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
US20080207577A1 (en) * 2005-07-11 2008-08-28 Astrazeneca Ab Combination I
EP1945240B1 (en) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereof
US20080200441A1 (en) * 2007-02-14 2008-08-21 University Of Southern California Estrogen receptor modulators associated pharmaceutical compositions and methods of use
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) * 1964-03-24 Chioacyl
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
US3357974A (en) * 1965-12-28 1967-12-12 Merck & Co Inc Processes for preparing 16alpha, 17alpha-acetals and ketals of 16alpha, 17alpha, 21-trihydroxy-delta4-pregnene-3, 20-diones
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
SE378109B (ru) * 1972-05-19 1975-08-18 Bofors Ab
SE378110B (ru) * 1972-05-19 1975-08-18 Bofors Ab
SE8008524L (sv) * 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
US4749649A (en) * 1983-05-16 1988-06-07 The Upjohn Company Microbial Δ1-dehydrogenation process using a scavenger of toxic oxygen
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
CN1060471A (zh) * 1985-04-04 1992-04-22 得拉科公司 新的16,17-缩醛取代雄甾烷-17β-酮类的制备方法
SE8604059D0 (sv) * 1986-09-25 1986-09-25 Astra Pharma Prod A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
HU203769B (en) * 1989-03-09 1991-09-30 Richter Gedeon Vegyeszet Process for producing new steroide derivatives and pharmaceutical compositions containing them
HU203562B (en) * 1989-03-09 1991-08-28 Richter Gedeon Vegyeszet Process for producing new steroide diols and pharmaceutical compositions containing them
PL164294B1 (pl) * 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
SE9100342D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroid esters
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids

Similar Documents

Publication Publication Date Title
RU93053630A (ru) Новые стероиды, способ их получения, фармацевтический препарат, способ лечения
RU93058351A (ru) Замещенные 3-аминохинуклидины, фармацевтические композиции на его основе, способы лечения, способ получения, промежуточные соединения
IT1240360B (it) Uso di un derivato dell'1alfa-idrossivitamina d per la preparazione di un medicamento per il trattamento dell' iperparatiroidismo
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
KR950702181A (ko) 20-위치가 변형된 비타민 D계열의 유도체, 이들의 제조 방법, 이 제조 방법을 위한 중간 생성물, 이들 유도체를 함유하는 제약 제제, 및 약제 제조를 위한 이들의 용도(Derivatives in the Vitamin D Series Modified at the 20 Position a Method of Preparing Such Derivatives, Intermediates Used in This Method, Pharmaceutical Preparations Containing the Derivatives and Their Use in the Preparation of Drugs)
RU2003101319A (ru) Фармацевтическая композиция, обладающая улучшенным противоопухолевым действием и/или сниженными побочными эффектами, содержащая противоопухолевый агент и производное гидроксамовой кислоты
TNSN92007A1 (fr) Nouveaux steroides
EP0393493A3 (en) Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
SE8704248D0 (sv) Medical use
EP0137440A3 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
EP0137441A3 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
IT8009551A0 (it) E-5-(2-alogenovinil-)-2'deossicitidine, loro metodo di preparazione e loro impiego per il trattamentodi malattie da virus
HUP0100012A2 (hu) Makrolid vegyületek alkalmazása rák és a makuláns elváltozások kezelésére
DE69027221D1 (de) Substituierte 4-phenyl-4-piperidincarboxamide mit sowohl lokalanästhetischer als auch schmerzlindernder wirkung sowie verfahren zur herstellung
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
IT1197427B (it) Metodo di formulazione di leghe metalliche ad uso odontoiatrico e complesso di leghe cosi' ottenute
ATE55248T1 (de) Arzneimittelkombination.
KR890012942A (ko) 5-치환된 오르니틴 유도체
KR880004810A (ko) 소화성 궤양 치료제
EP0029966A3 (de) Cephalosporinderivate, und deren Herstellung sowie entsprechende pharmazeutische Präparate
EP0679394A3 (en) Menatetronome derivative as antiarteriosclerotic agent
EP0373613A3 (en) Pyridine-3-percarboxylic acid monopersulfate
EP0379132A3 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
RU92004582A (ru) Этанольные аддукты, способ их получения и применение в качестве средств ингаляции при заболеваниях
LV10391A (lv) Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai